Ocular bandage gel passes initial human safety test

A statent from EyeGate Pharmaceuticals revealed its Ocular Bandage Gel had passed the initial safety and tolerability test.The gel was tested in comparison to current standard care practices, including the use of artificial tears and bandage contact lens (BCL), and the study group that used the gel reported complete wound closure in three days.{{quote-A:R-W:450-I:2-Q: The test results not only showed safety and tolerability results, but also donstrated encouraging signs of potential efficacy, -WHO:Dr Dan Durrie, Professor and Director of Refractive Surgery Services at the University of Kansas Medical Center}}Study lead Dr Dan Durrie, Professor and Director of Refractive Surgery Services at the University of Kansas Medical Center, said the results were exciting.“The test results not only showed safety and tolerability results, but also donstrated encouraging signs of potential efficacy, with nine of 12 subjects achieving complete closure by Day 3 and a significant reduction in average wound size just 24 hours after surgery,” Durrie explained.“These data suggest that the product has the potential to provide significant benefits in the treatment of various types of corneal epithelial defects.”The study involved 39 participants who had undergone photorefractive keratectomy and used the gel to assess its safety and performance for post-procedure therapy.The participants were divided into three groups and tested for two weeks.The first group used the EyeGate gel four times daily, the second group used the gel combined with BCL, and the third group used artificial tears and BCL.Frequency of application was the same for all groups at four times daily.